Literature DB >> 4169206

Alterations in human serum beta-1C-gobulin (C'3) in renal transplantation.

C B Carpenter, T J Gill, J P Merrill, G J Dammin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4169206     DOI： 10.1016/0002-9343(67)90244-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

1.  The complement system in renal homograft recipents.

Authors:  T Yokoyama; M Torisu; A L Durst; G Schroter; C G Groth; T E Starzl
Journal:  Surgery       Date:  1972-10       Impact factor: 3.982

2.  Autopsy findings in a long-surviving liver recipient.

Authors:  T Starzl; K A Porter; G Schroter; J Corman; C G Groth; H L Sharp
Journal:  N Engl J Med       Date:  1973-07-12       Impact factor: 91.245

3.  Alterations in plasma concentrations of immunoconglutinin and the C3 component of complement following human renal transplantation.

Authors:  J L Ngu; T M Barratt; B Hulme
Journal:  Clin Exp Immunol       Date:  1971-10       Impact factor: 4.330

4.  Clinical patterns of renal allograft rejection.

Authors:  W J Flanigan; F T Caldwell; G D Williams; T E Brewer; W E Glenn; J W Headstream; G S Campbell
Journal:  Ann Surg       Date:  1971-05       Impact factor: 12.969

5.  Canine early immunohistological responses to cardiac transplants.

Authors:  G J Thomas
Journal:  J Natl Med Assoc       Date:  1970-05       Impact factor: 1.798

6.  Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.

Authors:  H Hedberg; B Lundh; A B Laurell
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

7.  Serum complement after orthotopic transplantation of the human liver.

Authors:  M Torisu; T Yokoyama; P F Kohler; A L Durst; G Martineau; G Schroter; H Amemiya; C G Groth; T E Starzl
Journal:  Clin Exp Immunol       Date:  1972-09       Impact factor: 4.330

8.  Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).

Authors:  C B Carpenter; S Ruddy; I H Shehadeh; H J Müller-Eberhard; J P Merrill; K F Austen
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.

Authors:  D T Fearon; K F Austen; S Ruddy
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.